Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT00801320 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2020-09-10
Summary
The purpose of this research study is to collect tumor samples at the time of surgery and store them for possible use as part of an experimental vaccine study for the participants cancer in the future.
Conditions
- Ovarian Cancer
- Peritoneal Cancer
- Fallopian Tube Cancer
Interventions
- PROCEDURE
-
Tumor collection
Tumor collected at the time of planned surgery
Sponsors & Collaborators
- collaborator OTHER
-
Massachusetts General Hospital
collaborator OTHER -
National Cancer Institute (NCI)
collaborator NIH -
Beth Israel Deaconess Medical Center
lead OTHER
Principal Investigators
-
David Avigan, MD · Beth Israel Deaconess Medical Center
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2020-08-31
- Completion
- 2020-08-31
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
NCT01295489 ·Status: COMPLETED
-
Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00066729 ·Status: COMPLETED ·Phase: PHASE1
-
Risk of Ovarian Cancer in Patients With a Pelvic Mass
NCT00315692 ·Status: COMPLETED
-
The Treatment Preferences of Women Diagnosed With Ovarian Cancer
NCT03367260 ·Status: COMPLETED
-
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
NCT00002538 ·Status: COMPLETED ·Phase: PHASE2
-
Blood Collection From People With Ovarian Cancer
NCT02063464 ·Status: COMPLETED
-
Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer
NCT01096394 ·Status: COMPLETED
-
OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission
NCT00857545 ·Status: COMPLETED ·Phase: PHASE2
-
Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
NCT00055614 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
NCT00582205 ·Status: TERMINATED ·Phase: PHASE2
-
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
NCT05236686 ·Status: RECRUITING ·Phase: NA
-
Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function
NCT00525460 ·Status: COMPLETED
-
Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT05920798 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Ovarian Reserve Testing in Female Young Adult Cancer Survivors
NCT01421095 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma
NCT05714306 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
NCT04701645 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
NCT05691010 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)
NCT05827523 ·Status: RECRUITING ·Phase: PHASE3
-
Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage
NCT03150121 ·Status: UNKNOWN ·Phase: NA
-
Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00897039 ·Status: UNKNOWN
-
Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer
NCT00091273 ·Status: COMPLETED ·Phase: PHASE1
-
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
NCT00191646 ·Status: COMPLETED ·Phase: PHASE3
-
Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers
NCT00803569 ·Status: COMPLETED ·Phase: PHASE1
-
Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
NCT00112957 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
NCT01000259 ·Status: RECRUITING